Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused more than 96 million infections and over 2 million deaths worldwide so far. However, there is no approved vaccine available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the disease causative agent. Vaccine is the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yan-Feng, Wang, Ze-Jun, Jiang, Ren-Di, Hu, Xue, Zhang, Hua-Jun, Zhou, Yi-Wu, Gao, Ge, Chen, Ying, Peng, Yun, Liu, Mei-Qin, Zhang, Ya-Nan, Min, Juan, Lu, Jia, Gao, Xiao-Xiao, Guo, Jing, Peng, Cheng, Shen, Xu-Rui, Li, Qian, Zhao, Kai, Yang, Lian, Wan, Xin, Zhang, Bo, Wang, Wen-Hui, Wu, Jia, Zhou, Peng, Yang, Xing-Lou, Shen, Shuo, Shan, Chao, Yuan, Zhi-Ming, Shi, Zheng-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034048/
https://www.ncbi.nlm.nih.gov/pubmed/33835391
http://dx.doi.org/10.1007/s12250-021-00376-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034048/
https://www.ncbi.nlm.nih.gov/pubmed/33835391
http://dx.doi.org/10.1007/s12250-021-00376-w

Ejemplares similares